{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:43:28Z","timestamp":1761806608031,"version":"build-2065373602"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.nurt.2007.07.006","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T06:23:53Z","timestamp":1193120633000},"page":"666-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Modulating Co-Stimulation"],"prefix":"10.1016","volume":"4","author":[{"given":"Vissia","family":"Viglietta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2007.07.006_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/356607a0","article-title":"CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones","volume":"356","author":"Harding","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2007.07.006_bib2","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.4049\/jimmunol.147.10.3261","article-title":"Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation","volume":"147","author":"DeSilva","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.4049\/jimmunol.147.8.2461","article-title":"CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells","volume":"147","author":"Jenkins","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib4","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.4049\/jimmunol.147.6.1779","article-title":"The majority of CD4+8- thymocytes are functionally immature","volume":"147","author":"Ramsdell","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.4049\/jimmunol.146.4.1125","article-title":"IL-2 secretion and T cell clonal anergy are induced by distinct biochemical pathways","volume":"146","author":"Norton","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.273.5271.104","article-title":"T cell activation determined by T cell receptor number and tunable thresholds","volume":"273","author":"Viola","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.006_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/363156a0","article-title":"Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells","volume":"363","author":"Sloan-Lancaster","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2007.07.006_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.immunol.23.021704.115839","article-title":"TNF\/TNFR family members in costimulation of T cell responses","volume":"23","author":"Watts","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4049\/jimmunol.157.4.1333","article-title":"CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis","volume":"157","author":"Perrin","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib11","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","article-title":"CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells","volume":"183","author":"Krummel","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib12","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI117982","article-title":"Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation","volume":"95","author":"Cross","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/1074-7613(95)90063-2","article-title":"Blockade of CD28\/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE","volume":"3","author":"Miller","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.nurt.2007.07.006_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0092-8674(95)90349-6","article-title":"B7-1 and B7-2 costimulatory molecules activate differentially the Th1\/Th2 developmental pathways: application to autoimmune disease therapy","volume":"80","author":"Kuchroo","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2007.07.006_bib15","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1172\/JCI118274","article-title":"Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis","volume":"96","author":"Racke","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1084\/jem.190.5.733","article-title":"Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis","volume":"190","author":"Chang","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4049\/jimmunol.161.3.1104","article-title":"Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo","volume":"161","author":"Issazadeh","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib18","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.4049\/jimmunol.159.9.4212","article-title":"Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis model","volume":"159","author":"Gallon","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib19","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/eji.1830241217","article-title":"B7\/BB-1 antigen expression on adult human microglia studied in vitro and in situ","volume":"24","author":"Williams","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib20","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1084\/jem.182.6.1985","article-title":"Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions","volume":"182","author":"Windhagen","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib21","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1172\/JCI119455","article-title":"Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy","volume":"99","author":"Genc","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib22","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.4049\/jimmunol.162.3.1859","article-title":"B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis","volume":"162","author":"Peterson","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.4049\/jimmunol.157.4.1752","article-title":"Induction of autoimmunity in the absence of CD28 costimulation","volume":"157","author":"Bachmaier","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.162.1.203","article-title":"CD28-deficient mice are highly resistant to collagen-induced arthritis","volume":"162","author":"Tada","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.181.3.1145","article-title":"Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse","volume":"181","author":"Lenschow","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib26","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.154.3.1481","article-title":"Role of B7:CD28\/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis","volume":"154","author":"Perrin","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1126\/science.7520604","article-title":"Treatment of murine lupus with CTLA4Ig","volume":"265","author":"Finck","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.006_bib28","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.4049\/jimmunol.162.8.4490","article-title":"CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis","volume":"162","author":"Oliveira-dos-Santos","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4049\/jimmunol.164.1.136","article-title":"A critical role for B7\/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade","volume":"164","author":"Girvin","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eji.1830110307","article-title":"The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis","volume":"11","author":"Ben-Nun","year":"1981","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4049\/jimmunol.135.1.223","article-title":"A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis","volume":"153","author":"Vandenbark","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.iy.08.040190.003051","article-title":"The T lymphocyte in experimental allergic encephalomyelitis","volume":"8","author":"Zamvil","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1212\/WNL.46.1.12","article-title":"Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.006_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/346183a0","article-title":"T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis","volume":"346","author":"Ota","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2007.07.006_bib35","first-page":"101","article-title":"Encephalitogenic epitopes of myelin basic protein","volume":"46","author":"Fritz","year":"1989","journal-title":"Chem Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.iy.10.040192.001101","article-title":"Immunological aspects of demyelinating diseases","volume":"10","author":"Martin","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4049\/jimmunol.161.1.192","article-title":"Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis","volume":"161","author":"Karandikar","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1084\/jem.184.2.783","article-title":"CTLA-4: a negative regulator of autoimmune disease","volume":"184","author":"Karandikar","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-5728(96)00168-3","article-title":"Specific blockade of CTLA-4\/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis","volume":"73","author":"Hurwitz","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib40","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<3904::AID-IMMU3904>3.0.CO;2-5","article-title":"Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis","volume":"28","author":"Croxford","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib41","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.4049\/jimmunol.163.3.1704","article-title":"Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis","volume":"163","author":"Perrin","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0165-5728(99)00022-3","article-title":"Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis","volume":"96","author":"Schaub","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0167-5699(92)90068-I","article-title":"CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation","volume":"13","author":"Noelle","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.nurt.2007.07.006_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00919969","article-title":"The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39","volume":"13","author":"Marshall","year":"1993","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib45","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/eji.1830241248","article-title":"Properties of mouse CD40","volume":"24","author":"Klaus","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib46","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","article-title":"Activation of human dendritic cells through CD40 cross-linking","volume":"180","author":"Caux","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib47","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.4049\/jimmunol.155.10.4521","article-title":"CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system","volume":"155","author":"Khoury","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib48","first-page":"370","article-title":"CTLA4Ig: effects on cellular and humoral immunity and macrophage activation","volume":"5","author":"Schaub","year":"1997","journal-title":"Exp Nephrol"},{"key":"10.1016\/j.nurt.2007.07.006_bib49","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","article-title":"Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40","volume":"261","author":"Durie","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.006_bib50","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.4049\/jimmunol.157.7.3159","article-title":"Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice","volume":"157","author":"Early","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib51","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.4049\/jimmunol.159.7.3104","article-title":"Long-term inhibition of murine lupus by brief simultaneous blockade of the B7\/CD28 and CD40\/gp39 costimulation pathways","volume":"159","author":"Daikh","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib52","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.4049\/jimmunol.159.9.4150","article-title":"Regulation of C-C chemokine production by murine T cells by CD28\/B7 costimulation","volume":"159","author":"Herold","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1681\/ASN.V641143","article-title":"T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction","volume":"6","author":"Sayegh","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nurt.2007.07.006_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/08830189909043024","article-title":"Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease","volume":"18","author":"Khoury","year":"1999","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","article-title":"CTLA-4 can function as a negative regulator of T cell activation","volume":"1","author":"Walunas","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.nurt.2007.07.006_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib57","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.4049\/jimmunol.144.12.4579","article-title":"The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells","volume":"144","author":"Van Seventer","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib58","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/341619a0","article-title":"T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1","volume":"341","author":"Dustin","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2007.07.006_bib59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/339061a0","article-title":"Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1","volume":"339","author":"Staunton","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2007.07.006_bib60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1523-1747.2000.00abs-8.x","article-title":"Anti-CD11a treatment for psoriasis concurrently increases circulating T-cells and decreases plaque T-cells, consistent with inhibition of cutaneous T-cell trafficking","volume":"115","author":"Krueger","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.nurt.2007.07.006_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0190-9622(00)90214-7","article-title":"Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis","volume":"42","author":"Gottlieb","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nurt.2007.07.006_bib62","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/gast.2001.26260","article-title":"A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn\u2019s disease","volume":"121","author":"Gordon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nurt.2007.07.006_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJMe020157","article-title":"Alpha4 integrins as therapeutic targets in autoimmune disease","volume":"348","author":"von Andrian","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib64","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib65","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib66","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis","volume":"353","author":"Kleinschmidt-DeMasters","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn\u2019s disease","volume":"353","author":"Van Assche","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib69","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib70","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/eji.200324270","article-title":"Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis","volume":"33","author":"Rodig","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib71","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.193.7.839","article-title":"B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells","volume":"193","author":"Tseng","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib74","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.nurt.2007.07.006_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib78","first-page":"1410","article-title":"CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid","volume":"30","author":"Hatachi","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.nurt.2007.07.006_bib79","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI11220","article-title":"CD28-independent induction of experimental autoimmune encephalomyelitis","volume":"107","author":"Chitnis","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jneuroim.2006.09.006","article-title":"CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis","volume":"181","author":"Krakauer","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib81","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nurt.2007.07.006_bib82","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1182\/blood-2006-09-044826","article-title":"PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors","volume":"109","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.nurt.2007.07.006_bib83","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20061800","article-title":"Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade","volume":"203","author":"Freeman","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib84","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib85","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1084\/jem.20061496","article-title":"PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection","volume":"203","author":"Petrovas","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib86","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.4049\/jimmunol.154.11.5757","article-title":"Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response","volume":"154","author":"Lucas","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib87","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.156.3.1006","article-title":"CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance","volume":"156","author":"Walunas","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib88","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.4049\/jimmunol.157.9.3909","article-title":"CD28\/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation","volume":"157","author":"Sperling","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib89","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1074-7613(00)80376-3","article-title":"Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation","volume":"7","author":"Bachmann","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.nurt.2007.07.006_bib90","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1172\/JCI119873","article-title":"Following the fate of individual T cells throughout activation and clonal expansion","volume":"100","author":"Wells","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib91","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.4049\/jimmunol.162.9.5212","article-title":"Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity","volume":"162","author":"Gudmundsdottir","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib92","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1126\/science.1846244","article-title":"Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28","volume":"251","author":"Fraser","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.006_bib93","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.4049\/jimmunol.162.4.1947","article-title":"The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival","volume":"162","author":"Judge","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib94","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.158.12.5791","article-title":"IL-6 rescues resting mouse T cells from apoptosis","volume":"158","author":"Teague","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib95","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.4049\/jimmunol.158.10.4714","article-title":"CD28 engagement and proinflammatory cytokines contribute to T cell expansion and long-term survival in vivo","volume":"158","author":"Vella","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib96","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4049\/jimmunol.155.3.1032","article-title":"Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4","volume":"155","author":"Kearney","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib97","doi-asserted-by":"crossref","first-page":"R923","DOI":"10.1016\/S0960-9822(00)00870-8","article-title":"Information transfer at the immunological synapse","volume":"10","author":"Delon","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.nurt.2007.07.006_bib98","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.4049\/jimmunol.152.6.2675","article-title":"Naive versus memory CD4 T cell response to antigen","volume":"152","author":"Croft","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib99","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.164.9.4465","article-title":"The roles of CD28 and CD40 ligand in T cell activation and tolerance","volume":"164","author":"Howland","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4049\/jimmunol.164.1.265","article-title":"Functional responses and costimulator dependence of memory CD4+ T cells","volume":"164","author":"London","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib101","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1172\/JCI1528","article-title":"Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients","volume":"101","author":"Lovett-Racke","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib102","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1006\/cimm.1997.1137","article-title":"High concentrations of antigenic ligand activate and do not tolerize naive CD4 T cells in the absence of CD28\/B7 costimulation","volume":"179","author":"Teh","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib103","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4049\/jimmunol.160.3.1532","article-title":"Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation","volume":"160","author":"Scholz","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib104","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1084\/jem.178.5.1801","article-title":"Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion","volume":"178","author":"Lin","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/096368979700600510","article-title":"CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice","volume":"6","author":"Weber","year":"1997","journal-title":"Cell Transplant"},{"key":"10.1016\/j.nurt.2007.07.006_bib106","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/art.10294","article-title":"Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion","volume":"46","author":"Moreland","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nurt.2007.07.006_bib107","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ni846","article-title":"CTLA-4-Ig regulates tryptophan catabolism in vivo","volume":"3","author":"Grohmann","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib108","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.45.2.367","article-title":"Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes","volume":"45","author":"Satoh","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.006_bib109","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.nurt.2007.07.006_bib110","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","article-title":"Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells","volume":"171","author":"Tang","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib111","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1056\/NEJMoa035075","article-title":"Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig","volume":"349","author":"Kremer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib112","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/art.21201","article-title":"Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial","volume":"52","author":"Kremer","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nurt.2007.07.006_bib113","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib114","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.192.5.681","article-title":"Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells","volume":"192","author":"Abrams","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib115","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Costimulation blockade with belatacept in renal transplantation","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib116","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0733-8619(18)31147-2","article-title":"Relevance of experimental allergic encephalomyelitis to multiple sclerosis","volume":"1","author":"Arnason","year":"1983","journal-title":"Neurol Clin"},{"key":"10.1016\/j.nurt.2007.07.006_bib117","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.1830240947","article-title":"Experimental allergic encephalomyelitis (EAE) in mice lacking CD4+ T cells","volume":"24","author":"Koh","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib118","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.1689076","article-title":"T cells responsive to myelin basic protein in patients with multiple sclerosis","volume":"247","author":"Allegretta","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.006_bib119","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.183.3.801","article-title":"The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells","volume":"183","author":"Griggs","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.nurt.2007.07.006_bib120","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2567.1997.00421.x","article-title":"Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction","volume":"90","author":"Carayanniotis","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.nurt.2007.07.006_bib121","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.159.9.4620","article-title":"CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice","volume":"159","author":"Balasa","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.006_bib122","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1172\/JCI5388","article-title":"Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis","volume":"103","author":"Howard","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.006_bib123","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/rheumatology\/kei118","article-title":"Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism","volume":"45","author":"Nakamura","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.nurt.2007.07.006_bib124","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.bjp.0706828","article-title":"Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates","volume":"148","author":"Kelley","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nurt.2007.07.006_bib125","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1158\/0008-5472.CAN-04-4125","article-title":"Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma","volume":"65","author":"Tai","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.nurt.2007.07.006_bib126","doi-asserted-by":"crossref","first-page":"11712","DOI":"10.1158\/0008-5472.CAN-05-1657","article-title":"Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications","volume":"65","author":"Tai","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.nurt.2007.07.006_bib127","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.4049\/jimmunol.176.11.6543","article-title":"Stimulation through CD40 on mouse and human renal cell carcinomas triggers cytokine production, leukocyte recruitment, and antitumor responses that can be independent of host CD40 expression","volume":"176","author":"Shorts","year":"2006","journal-title":"J Immunol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923006141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2007.07.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:39:18Z","timestamp":1761806358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923006141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1878747923006141"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2007.07.006","relation":{},"ISSN":["1878-7479"],"issn-type":[{"type":"print","value":"1878-7479"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating Co-Stimulation","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2007.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}